Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome

BACKGROUND: The G protein-coupled oestrogen receptor, GPER, has been suggested as an alternative oestrogen receptor. Our purpose was to investigate the potential of GPER as a prognostic and predictive marker in endometrial carcinoma and to search for new drug candidates to improve treatment of aggre...

Descripción completa

Detalles Bibliográficos
Autores principales: Krakstad, C, Trovik, J, Wik, E, Engelsen, I B, Werner, H M J, Birkeland, E, Raeder, M B, Øyan, A M, Stefansson, I M, Kalland, K H, Akslen, L A, Salvesen, H B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349187/
https://www.ncbi.nlm.nih.gov/pubmed/22415229
http://dx.doi.org/10.1038/bjc.2012.91

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349187/
https://www.ncbi.nlm.nih.gov/pubmed/22415229
http://dx.doi.org/10.1038/bjc.2012.91

Ejemplares similares